MDMarc Ditzhaus

Marc Ditzhaus

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc Ditzhaus has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inference for competing risks based on area between curves statistics

    by Simon Mack, Marc Ditzhaus, Merle Munko, Markus Pauly

    In competing risks models, cumulative incidence functions are commonly compared to infer differences between groups. Many existing inference methods, however, struggle when these functions cross during the time frame of interest. To address this problem, we investigate a test statistic based on the area between cumulative incidence functions. As the corresponding limiting distribution depends on quantities that are typically unknown, we propose a wild bootstrap approach to obtain a feasible and asymptotically valid two-sample test. The finite sample performance of the proposed method, in comparison with existing methods, is examined in an extensive simulation study.

  • Open Access

    Early and Late Buzzards: Comparing Different Approaches for Quantile‐Based Multiple Testing in Heavy‐Tailed Wildlife Research Data

    by Marléne Baumeister, Merle Munko, Kai‐Philipp Gladow, Marc Ditzhaus, Nayden Chakarov, Markus Pauly

    In medical, ecological, and psychological research, there is a need for methods to handle multiple testing, for example, to consider group comparisons with more than two groups. Typical approaches that deal with multiple testing are mean‐ or variance‐based which can be less effective in the context of heavy‐tailed and skewed data. Here, the median is the preferred measure of location and the interquartile range (IQR) is an adequate alternative to the variance. Therefore, it may be fruitful to formulate research questions of interest in terms of the median or the IQR. For this reason, we compare different inference approaches for two‐sided and noninferiority hypotheses formulated in terms of medians or IQRs in an extensive simulation study. We consider multiple contrast testing procedures combined with a bootstrap method as well as testing procedures with Bonferroni correction. As an example of a multiple testing problem based on heavy‐tailed data, we analyze an ecological trait variation in early and late breeding in a medium‐sized bird of prey.


  • Open Access

    Multiple tests for restricted mean time lost with competing risks data

    by Merle Munko, Dennis Dobler, Marc Ditzhaus

    Easy-to-interpret effect estimands are highly desirable in survival analysis. In the competing risks framework, one good candidate is the restricted mean time lost (RMTL). It is defined as the area under the cumulative incidence function up to a prespecified time point and, thus, it summarizes the cumulative incidence function into a meaningful estimand. While existing RMTL-based tests are limited to 2-sample comparisons and mostly to 2 event types, we aim to develop general contrast tests for factorial designs and an arbitrary number of event types based on a Wald-type test statistic. Furthermore, we avoid the often-made, rather restrictive continuity assumption on the event time distribution. This allows for ties in the data, which often occur in practical applications, for example, when event times are measured in whole days. In addition, we develop more reliable tests for RMTL comparisons that are based on a permutation approach to improve the small sample performance. In a second step, multiple tests for RMTL comparisons are developed to test several null hypotheses simultaneously. Here, we incorporate the asymptotically exact dependence structure between the local test statistics to gain more power. The small sample performance of the proposed testing procedures is analyzed in simulations and finally illustrated by analyzing a real-data example about leukemia patients who underwent bone marrow transplantation.


  • Open Access

    Multiple comparison procedures for simultaneous inference in functional MANOVA

    by Merle Munko, Marc Ditzhaus, Markus Pauly, Łukasz Smaga

    Functional data analysis is becoming increasingly popular to study data from real-valued random functions. Nevertheless, there is a lack of multiple testing procedures for such data. These are particularly important in factorial designs to compare different groups or to infer factor effects. We propose a new class of testing procedures for arbitrary linear hypotheses in general factorial designs with functional data. Our methods allow global as well as multiple inference of both, univariate and multivariate mean functions without assuming particular error distributions nor homoscedasticity. That is, we allow for different structures of the covariance functions between groups. To this end, we use pointwise quadratic-form-type test functions that take potential heteroscedasticity into account. Taking the supremum over each test function, we define a class of local test statistics. We analyze their (joint) asymptotic behaviour and propose a resampling approach to approximate the limit distributions. The resulting global and multiple testing procedures are asymptotic valid under weak conditions and applicable in general functional multivariate analysis of variance (MANOVA) settings. We evaluate their small-sample performance in extensive simulations and finally illustrate their applicability by analyzing a multivariate functional air pollution data set. The new procedures are implemented in the R package gmtFD.


  • Open Access

    RMST‐based multiple contrast tests in general factorial designs

    by Merle Munko, Marc Ditzhaus, Dennis Dobler, Jon Genuneit

    Several methods in survival analysis are based on the proportional hazards assumption. However, this assumption is very restrictive and often not justifiable in practice. Therefore, effect estimands that do not rely on the proportional hazards assumption are highly desirable in practical applications. One popular example for this is the restricted mean survival time (RMST). It is defined as the area under the survival curve up to a prespecified time point and, thus, summarizes the survival curve into a meaningful estimand. For two‐sample comparisons based on the RMST, previous research found the inflation of the type I error of the asymptotic test for small samples and, therefore, a two‐sample permutation test has already been developed. The first goal of the present paper is to further extend the permutation test for general factorial designs and general contrast hypotheses by considering a Wald‐type test statistic and its asymptotic behavior. Additionally, a groupwise bootstrap approach is considered. Moreover, when a global test detects a significant difference by comparing the RMSTs of more than two groups, it is of interest which specific RMST differences cause the result. However, global tests do not provide this information. Therefore, multiple tests for the RMST are developed in a second step to infer several null hypotheses simultaneously. Hereby, the asymptotically exact dependence structure between the local test statistics is incorporated to gain more power. Finally, the small sample performance of the proposed global and multiple testing procedures is analyzed in simulations and illustrated in a real data example.


  • Open Access

    Studentized permutation method for comparing two restricted mean survival times with small sample from randomized trials

    by Marc Ditzhaus, Menggang Yu, Jin Xu

    Recent observations, especially in cancer immunotherapy clinical trials with time‐to‐event outcomes, show that the commonly used proportional hazard assumption is often not justifiable, hampering an appropriate analysis of the data by hazard ratios. An attractive alternative advocated is given by the restricted mean survival time (RMST), which does not rely on any model assumption and can always be interpreted intuitively. Since methods for the RMST based on asymptotic theory suffer from inflated type‐I error under small sample sizes, a permutation test was proposed recently leading to more convincing results in simulations. However, classical permutation strategies require an exchangeable data setup between comparison groups which may be limiting in practice. Besides, it is not possible to invert related testing procedures to obtain valid confidence intervals, which can provide more in‐depth information. In this paper, we address these limitations by proposing a studentized permutation test as well as respective permutation‐based confidence intervals. In an extensive simulation study, we demonstrate the advantage of our new method, especially in situations with relatively small sample sizes and unbalanced groups. Finally, we illustrate the application of the proposed method by re‐analyzing data from a recent lung cancer clinical trial.


  • Biomarker-driven therapies for metastatic uveal melanoma: A prospective precision oncology feasibility study

    by Serge Leyvraz, Frank Konietschke, Caroline Peuker, Moritz Schütte, Thomas Kessler, Sebastian Ochsenreither, Marc Ditzhaus, Erin D. Sprünken, Gina Dörpholz, Mario Lamping, et al.


  • Open Access

    Testing marginal homogeneity in Hilbert spaces with applications to stock market returns

    by Marc Ditzhaus, Daniel Gaigall

    This paper considers a paired data framework and discusses the question of marginal homogeneity of bivariate high-dimensional or functional data. The related testing problem can be endowed into a more general setting for paired random variables taking values in a general Hilbert space. To address this problem, a Cramér–von-Mises type test statistic is applied and a bootstrap procedure is suggested to obtain critical values and finally a consistent test. The desired properties of a bootstrap test can be derived that are asymptotic exactness under the null hypothesis and consistency under alternatives. Simulations show the quality of the test in the finite sample case. A possible application is the comparison of two possibly dependent stock market returns based on functional data. The approach is demonstrated based on historical data for different stock market indices.


  • Open Access

    Long-Term Efficacy and Impact on Mortality of Remote Magnetic Navigation Guided Catheter Ablation of Ventricular Arrhythmias

    by Denise Guckel, Sarah Niemann, Marc Ditzhaus, Stephan Molatta, Leonard Bergau, Thomas Fink, Vanessa Sciacca, Mustapha El Hamriti, Guram Imnadze, Philipp Steinhauer, et al.

    Remote magnetic navigation (RMN) facilitates ventricular arrhythmia (VA) ablation. This study aimed to evaluate the long-term efficacy of RMN-guided ablation for ventricular tachycardia (VT) and premature ventricular contractions (PVC). A total of 176 consecutive patients (mean age 53.23 ± 17.55 years, 37% female) underwent VA ablation for PVC (132 patients, 75%) or VT (44 patients, 25%). The cohort consisted of 119 patients (68%) with idiopathic VA, 31 (18%) with ischemic (ICM), and 26 (15%) with dilated cardiomyopathy (DCM). VA recurrence was observed in 69 patients (39%, mean age 51.71 ± 19.91 years, 23% female) during a follow-up period of 5.48 years (first quartile 770.50 days, second quartile 1101.50 days, third quartile 1615.50 days). Left ventricular ejection fraction p = 0.031*). Multivariate analyses found DCM to be an independent predictor (IP) for VA recurrence (p < 0.001*, hazard ratio (HR) 3.74, confidence interval (CI) 1.58–8.88). ICM resulted in a lower increase in VA recurrence (p = 0.221, HR 1.49, CI 0.79–2.81). Class I/III/IV antiarrhythmic drug therapy (AADs) was also identified as IP for recurrence (p = 0.030*, HR 2.48, CI 1.11–5.68). A total of 16 patients (9%) died within the observational period. RMN-guided ablation of VA lead to acceptable long-term results. An impaired LV function, DCM, and AADs were associated with a significant risk for VA recurrence. Personalized paths are needed to improve efficacy and outcome.